Holly Ryan, MD
Vascular Surgery · Salt Lake City, UTNPI 1730610015
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,754 of the $5,313 with a category attached, or 70.7%. 12 manufacturers reported payments, led by Silk Road Medical, Inc. at 46.9% of the total. Reporting peaked in 2023 at $2,764 and has fallen 65.6% since, to $952 in 2025.
Across 66 payments — averaging $80.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Silk Road Medical, Inc.$2K
- W. L. Gore & Associates, Inc.$2K
- Inari Medical, Inc.$329
- Stryker$154
- Abbott$119
- Penumbra, Inc.$119
- plus $348 from 6 others
What the payments were for
- Travel & lodging$1,55929%
- Food & beverage$3,75471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Silk Road Medical, Inc. | 13 | $2,492 |
| W. L. Gore & Associates, Inc. | 31 | $1,752 |
| Inari Medical, Inc. | 2 | $329 |
| Stryker | 2 | $154 |
| Abbott | 1 | $119 |
| Penumbra, Inc. | 2 | $119 |
| Medtronic | 5 | $96 |
| Lemaitre Vascular, Inc. | 4 | $90 |
| Cook Medical LLC | 2 | $89 |
| Boston Scientific | 1 | $29 |
| Philips North America LLC | 2 | $29 |
| Integra Lifesciences Corporation | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENROUTE Transcarotid Neuroprotection System$2,561
- ENROUTE Transcarotid Stent$2,310
- CT THROMBECTOMY SYSTEM KIT$472
- FLOWTRIEVER CATHETER, S$472
- GORE TAG Thoracic Branch Endoprosthesis$350
- GORE VIABAHN VBX Balloon Expandable Endo$283
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$251
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$190
- GORE EXCLUDER AAA Endoprosthesis$141
- GORE ACUSEAL Vascular Graft$131
- JETi Peripheral Catheter$119
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$109
- Indigo System$102
How this compares
$5,313 in reported general payments places this provider in the 70th percentile of 31 vascular surgery providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 12 | $6,829 |
| ClopidogrelClopidogrel Bisulfate | 14 | $180 |
| Tramadol Hcl | 27 | $49 |
| Tamsulosin Hcl | 15 | $37 |
| Oxycodone Hcl | 12 | $36 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Salt Lake City
- Craig SelzmanSalt Lake City$11K
- Thomas SerenaSalt Lake City$8K
- Benjamin BrookeSalt Lake City$4K
- Kaohinani LongwolfSalt Lake City$4K
- Alexander SchurmanSalt Lake City$4K
- Ian SchliederSalt Lake City$3K
- Steven SimperSalt Lake City$2K
- Mark SarfatiSalt Lake City$1K
- Luke DegraaffSalt Lake City$881
- Larry KraissSalt Lake City$716
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.